Our Research Research Groups We firmly believe in sharing knowledge. From experienced veterans to talented young researchers, we work together in 62 groups. Kép Search Category Category AMOLF Amsterdam UMC Erasmus MC Hubrecht Institute Leiden University LUMC NKI Princess Máxima Center Radboud UMC Radboud University Sanquin UMC Utrecht UMCG NKI Reuven Agami Group Controlling cancer by RNA NKI Leila Akkari Group Immune cells and macrophages in therapeutically challenging tumors NKI René Bernards Group Functional Cancer Genetics Princess Máxima Center Ruben van Boxtel Group Cancer Etiology, Mutagenesis and Clonal Evolution NKI Thijn Brummelkamp Group Experimental biomedical genetics LUMC Sjoerd van der Burg Group Immunotherapy; T-cells; immune regulation; clinical trials UMC Utrecht Boudewijn Burgering Group Signal transduction and metabolism Erasmus MC Miao-Ping Chien Group Single cell technology, advanced imaging & quantitative analysis, cancer-driving cells, target discovery Hubrecht Institute Hans Clevers Group Adult Stem cells and cancer UMC Utrecht Maria Rodriguez Colman Group Metabolism, Cancer and Stem Cells Erasmus MC Ruud Delwel Group Molecular genetics of AML Amsterdam UMC Sarah Derks Group GEA, genome-immunome interactions, intratumor heterogeneity, targeted-immunotherapy LUMC Peter ten Dijke Group Chemical Signaling Princess Máxima Center Jarno Drost Group Molecular dissection of childhood solid tumors Radboud UMC Carl Figdor Group Chemical Immunology, antigen presenting cells, Immunotherapy UMCG Lude Franke Group Functional genomics AMOLF Kristina Ganzinger Group Single-molecule imaging of immune receptor organisation & immune cell membrane models Amsterdam UMC Joep Grootjans Group The role of the immune system in cancer development and progression Radboud University Maike Hansen Group Single Cell Analysis, Cell Fate Decisions Princess Máxima Center Sebastiaan van Heesch Group Microprotein biology and immunotherapy target discovery in childhood cancer Leiden University Laura Heitman Group GPCR, allosteric modulation, target binding kinetics, small molecule Princess Máxima Center Jan Hoeijmakers Group DNA repair NKI Jos Jonkers Group Mouse models of breast cancer Erasmus MC Roland Kanaar Group Molecular radiation biology Hubrecht Institute Jop Kind Group Spatiotemporal regulation of genomic function Hubrecht Institute Puck Knipscheer Group Molecular mechanisms and regulation of DNA repair Hubrecht Institute Geert Kops Group Cell division & chromosome segregation UMC Utrecht Wouter de Laat Group Biomedical genomics UMC Utrecht Susanne Lens Group Genome instability NKI Tineke Lenstra Group Transcription dynamics, single-molecule imaging Radboud UMC Geert Litjens Group Applications of AI in oncology Erasmus MC Jurgen Marteijn Group Transcription Stress & Genome Stability UMC Utrecht Madelon Maurice Group Mechanisms of cell-cell communication and tissue self-organization Princess Máxima Center René Medema Group Cell Division and Cancer Amsterdam UMC Jan Paul Medema Group Experimental Oncology and Radiobiology UMC Utrecht Linde Meyaard Group Infection & immunity LUMC Jacques Neefjes Group Cell biology, infection, cancer and cancer drugs LUMC Sylvie Noordermeer Group DNA damage repair, homologous recombination, BRCA1 Hubrecht Institute Alexander van Oudenaarden Group Quantitative biology of development & stem cells NKI Daniel Peeper Group Functional genomics for rational tumor and immune cell combination therapy NKI Anastassis Perrakis Group Structural Biology, Cell Division, Lysolipid Signalling Leiden University Sebastian Pomplun Group Drug discovery – Novel chemical modalities – Nucleic acid binding proteins NKI Jacco van Rheenen Group Intravital Microscopy UMC Utrecht Jeroen de Ridder Group Bioinformatics, Machine learning and AI, Nanopore Sequencing Princess Máxima Center Anne Rios Group Cancer, immunotherapy development, high resolution 3D imaging, organoid technology, bio-engineering Hubrecht Institute Danny Sahtoe Group Protein Design Erasmus MC Rebekka Schneider Group Hematopoietic stem cells; leukemia; bone marrow failure; myelodysplastic syndrome; myeloproliferative neoplasms; genetic fate tracing; CRISPR-Cas9; scRNA sequencing NKI Ton Schumacher Group Molecular Oncology & Immunology NKI Titia Sixma Group Structural Biology Princess Máxima Center Hugo Snippert Group Functional heterogeneity in cancer NKI Bas van Steensel Group Genome Biology and Gene Regulation Leiden University Mario van der Stelt Group Medicinal chemistry, drug discovery, chemical biology Erasmus MC Nitika Taneja Group 3-D chromatin remodeling and replication Hubrecht Institute Marvin Tanenbaum Group Single molecule analysis of gene expression dynamics NKI Daniela Thommen Group Precision cancer immunotherapy Radboud University Michiel Vermeulen Group Proteomics & Chromatin biology Amsterdam UMC Louis Vermeulen Group Cancer molecular subtypes, stem cell dynamics, colorectal cancer, microenvironment NKI Karin de Visser Group Inflammation and cancer NKI Emile Voest Group Genomics, precision medicine, organoids, immunotherapy NKI Lodewyk Wessels Group Computational Biology Sanquin Monika Wolkers Group T cell effector function, post-transcriptional gene regulation, RNA binding proteins NKI Wilbert Zwart Group Hormones and Cancer
Erasmus MC Miao-Ping Chien Group Single cell technology, advanced imaging & quantitative analysis, cancer-driving cells, target discovery
Amsterdam UMC Sarah Derks Group GEA, genome-immunome interactions, intratumor heterogeneity, targeted-immunotherapy
AMOLF Kristina Ganzinger Group Single-molecule imaging of immune receptor organisation & immune cell membrane models
Amsterdam UMC Joep Grootjans Group The role of the immune system in cancer development and progression
Princess Máxima Center Sebastiaan van Heesch Group Microprotein biology and immunotherapy target discovery in childhood cancer
Leiden University Laura Heitman Group GPCR, allosteric modulation, target binding kinetics, small molecule
Leiden University Sebastian Pomplun Group Drug discovery – Novel chemical modalities – Nucleic acid binding proteins
Princess Máxima Center Anne Rios Group Cancer, immunotherapy development, high resolution 3D imaging, organoid technology, bio-engineering
Erasmus MC Rebekka Schneider Group Hematopoietic stem cells; leukemia; bone marrow failure; myelodysplastic syndrome; myeloproliferative neoplasms; genetic fate tracing; CRISPR-Cas9; scRNA sequencing
Amsterdam UMC Louis Vermeulen Group Cancer molecular subtypes, stem cell dynamics, colorectal cancer, microenvironment
Sanquin Monika Wolkers Group T cell effector function, post-transcriptional gene regulation, RNA binding proteins
